BE755826A - Compns for treatment of cardiac disorders - contg creative-o-phosphate - Google Patents

Compns for treatment of cardiac disorders - contg creative-o-phosphate

Info

Publication number
BE755826A
BE755826A BE755826DA BE755826A BE 755826 A BE755826 A BE 755826A BE 755826D A BE755826D A BE 755826DA BE 755826 A BE755826 A BE 755826A
Authority
BE
Belgium
Prior art keywords
compns
phosphate
treatment
contg
creative
Prior art date
Application number
Other languages
French (fr)
Original Assignee
Siphar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of BE755826A publication Critical patent/BE755826A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compns. for the treatment of certain cardiac disorders suitable for oral admin. contain creatine-O-phosphate of formula I. The daily dose of I is 5-25 mg/kg body wt. I effects the contractility of the myocardium, and alleviates cardiac insufficiency, arrythmia and conduction disorders. I is pref., formulated as tablets, which effervesce on contact with water. A suitable tablet lubricant is polyethylene glycol of mol. wt. 4000-20000. The compns. may contain vitamin C and/or vitamin B6, which potentiate the action of I.
BE755826D 1970-09-07 Compns for treatment of cardiac disorders - contg creative-o-phosphate BE755826A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE755826 1970-09-07

Publications (1)

Publication Number Publication Date
BE755826A true BE755826A (en) 1971-02-15

Family

ID=3856979

Family Applications (1)

Application Number Title Priority Date Filing Date
BE755826D BE755826A (en) 1970-09-07 Compns for treatment of cardiac disorders - contg creative-o-phosphate

Country Status (1)

Country Link
BE (1) BE755826A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773473A (en) * 1997-04-15 1998-06-30 Green; Jerold L. Creatine supplement

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773473A (en) * 1997-04-15 1998-06-30 Green; Jerold L. Creatine supplement

Similar Documents

Publication Publication Date Title
ZA711412B (en) Orally administrable drug dosage form having delayed action
BE755826A (en) Compns for treatment of cardiac disorders - contg creative-o-phosphate
IT1052282B (en) COMPOSITION FOR THE TREATMENT OF ACNE
ES432026A1 (en) Pharmacologically active anilinobenzothiazoles
FR2081478A1 (en) Treatment of acne and psoriasis with vitamin - a acids
FR2155927A1 (en) 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity
GB950162A (en) Medicines for the treatment of hepatic disorders
GB911482A (en) Pharmaceutical tablets comprising a synergistic combination including salts of ª--phenoxyethyl penicillin
GB931921A (en) Therapeutic compositions intended for the treatment of any hepatic malfunctionings
ES377822A1 (en) Dental preparations containing orotic acid
FR1242M (en) Medicament, which can be used in particular for the treatment of fungal diseases, based on griseofulvin derivatives.
GB914512A (en) Novel therapeutic compositions
FR2081580A1 (en) Pharmacol-active 2,4,6-trimethoxybenzoates
BE802626A (en) 1-Methyl-2-isopropyl-5-nitroimidazole compsns - for treatment of swine dysentery
FR2092649A1 (en) Oral antirheumatic compsn - of aceylsalicylic acid magnesium thiomalate, thiamine and ascorbic acid
USD232303S (en) Box blank
FR2059480A1 (en) Anticarcinogenic compns contng vitamin a - acids
FR2059478A1 (en) Anticarcinogenic compns contng vitamin a - acids
FR2081583A1 (en) Threonine proto-glutamate - as hepatoprotective agent
ES433702A1 (en) Papaverine thienyl-carboxylates and medicaments containing them
GB891445A (en) Pharmaceutical compositions comprising sulphonamido-thiadiazole derivatives
FR2088218A1 (en) Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states
Jirgl et al. The influence of propericiazine on the behavior of difficult delinquents.
GB908634A (en) Pharmaceutical compositions containing pararosaniline or derivatives thereof
GB976096A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SIPHAR S.A.

Effective date: 19860930